research Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19
This article is a discussion piece that examines the clinical symptoms of hyperandrogenic women with COVID-19, without reporting new research findings.
Search
forResearch
5 / 1000+ results 
research Clinical symptoms and sex steroid measurements in domestic ferrets (Mustela putorius furo) with hyperadrenocorticism
This study found no correlation between clinical signs and sex steroid levels in ferrets with hyperadrenocorticism and noted that androstenedione was elevated in many cases.
research Unusual symptoms of iron deficiency anemia (2 clinical observations)
This article reports two cases of iron deficiency anemia in Russian adolescent girls, highlighting the role of low iron stores at birth in developing anemia during puberty.
research Common Clinical signs and symptoms observed in Patients diagnosed with Thyrotoxicosis in Gujranwala, Pakistan
This study found a high prevalence of thyrotoxicosis among females in Gujranwala, Pakistan, particularly noting typical symptoms such as goiter, sweating, and menstrual irregularities.
research Trichotillomania: behavioral symptom or clinical syndrome? [clinical conference]
This discussion reviews the complexities of trichotillomania's symptoms, pathology, and treatment, but reports no new research findings; it highlights a specific illustrative case.
Community Join
5 / 1000+ resultscommunity Study Shows Karunjchirakam Chooranam Improves PCOS Symptoms
Karunjchirakam Chooranam, also known as black cumin, significantly improves PCOS symptoms. The conversation focuses on this treatment's effectiveness for PCOS.
community Creatine made all my high DHT symptoms return
Creatine may increase DHT levels, potentially causing symptoms like acne, oily hair, and hair shedding. Users report mixed experiences, with some avoiding creatine due to hair loss concerns and others seeing no impact.
community Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
Kintor Pharma completed patient enrollment for a Phase II trial in China for GT20029, a potential new treatment for hair loss. Some believe GT20029 could replace finasteride if effective, while others discuss finasteride's limited efficacy and potential underreported side effects.
community Update about Hair Follicle Glucose Metabolism: New Clinical Data Collection with Ex-President Of American Board Of Hair Restoration Surgery.
David Barreto shared that a London-based research group is conducting a 12-month trial for a new nutraceutical treatment for pattern hair loss, designed with Dr. Carlos Puig. The trial aims to provide robust data, with results expected in 1-2 years, potentially representing a significant advancement since finasteride’s introduction in 1997.
community Safety of RU-58841: I talked to the Pharma Company that researched it, Human Clinical Trials, and Potential Reasons for Discontinuation
The safety and effectiveness of RU-58841 as a hair loss treatment, with some users reporting side effects like chest pains, while others had positive results. The original research on RU-58841 was likely stopped due to financial issues, not safety concerns.
Learn
8 / 801 results- Are there clinical studies showing that KY19382 can regrow hair in androgenic alopecia? No clinical studies have proven KY19382 regrows hair in androgenic alopecia.
- What do clinical trials say about the safety and effectiveness of SCUBE3 for hair regrowth? No clinical trial of SCUBE3 for hair regrowth has been registered on ClinicalTrials.gov or published, so there is no human safety or effectiveness data. The evidence is limited to one 2022 laboratory and mouse study reporting that SCUBE3 activates hair follicle stem cells through TGF-beta signalling.
- Are there any clinical studies supporting follistatin as a hair loss treatment? There is no controlled human trial showing follistatin treats hair loss; the published work is mouse and laboratory biology on the activin/follistatin signalling system, plus one small 2011 phase 1 injection study of a combination product, so follistatin remains experimental and unapproved.
- What types of hair loss conditions are most commonly associated with tofacitinib use in clinical settings? Published studies link tofacitinib mainly to alopecia areata and its severe variants — as an off-label drug being studied for them, not as a cause of hair loss. The evidence is mostly small, open-label or retrospective, and relapse after stopping is commonly reported.
- When will GT20029 be commercially available, and are there any clinical trials on its use? GT20029 is not approved or commercially available anywhere and remains investigational. A published 12-week Phase II study in 180 Chinese men reports hair-count gains over placebo, but no long-term or Phase III data exists, so any launch is years away at best.
learn Neem Oil
natural substance from Neem tree with medicinal and pesticidal properties
learn Overview
learn Stem Cell Factor
learn KY19382
learn SCUBE3
learn Follistatin
learn Tofacitinib
learn GT20029
Clinics
6 / 500 results- 29
TrichologyHair TransplantCLINICAL HAIR&HEALTHOstrava · CZ - 33
Hair TransplantHair Loss TreatmentsClinical BédardMontréal, QC · CA - 11
Hair Loss TreatmentsClinical Francisco DuarteBelo Horizonte, MG · BR - 35
Hair Loss TreatmentsClinical Hair & beautyCórdoba, CB · AR - 12Hair Loss TreatmentsClinical Aesthetic SolvayLiège · BE
- 25Hair TransplantClinical Aesthetics of TulsaTulsa, OK · US
Experts
— no results